Allergy Diagnostics
SKU
MRR-436901065A32
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 5.92 billion
2030
USD 11.80 billion
2024
USD 6.49 billion
CAGR
10.35%
Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Global Forecast 2024-2030

[182 Pages Report] The Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024, at a CAGR 10.35% to reach USD 11.80 billion by 2030.

Allergy Diagnostics Market
To learn more about this report, request a free sample copy

An allergy diagnosis is a test performed by a qualified specialist to determine if the patient's body is allergic to known chemicals. Allergy diagnostics tests estimate the number of typical antibodies or proteins in the body that are associated with allergies. Rising cases of allergic diseases such as atopic dermatitis, hives, and allergic conjunctivitis are expected to elevate the need for accurate allergy diagnosis. The incidence of multiple allergic diseases among the population expands the preference for early detection and diagnosis of the allergen, creating a requirement for effective diagnostic tests or systems. However, limited awareness about allergic diseases and high costs of diagnostic tests, and the limited availability of trained professionals can impede the market development over the forecast period. Furthermore, the emerging emphasis on research activities to develop new allergy diagnostic tests or kits based on AI and ML by companies is creating an opportunity for market development.

Allergy Diagnostics Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
Regional Insights

Europe has a significant landscape in the allergy diagnostics market due to a developed pharmaceutical industry and increasing demand for therapeutics. The growing geriatric population and rising incidences of allergic conditions also contribute to the region’s growth. The market is expected to grow in the Americas in coming years owing to the high incidence of respiratory allergic disorders, rising awareness levels about allergy diagnostics, and the adoption of in vitro blood tests. The FDA has guided the food industry, consumers, and other stakeholders on the best ways to assess and manage allergen hazards in food. The Center for Biologics Evaluation and Research (CBER) regulates several allergenic products that contributed to market growth in North America. Asia-Pacific is expected to be the fastest-growing regional market due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools. Saudi Arabia has a growing landscape in the allergy diagnostics market, as the UAE manufactures and exports major parts of instruments and consumables required for allergy diagnostics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergy Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • This allergy drop startup raises $2M to bring at-home allergy testing to everyone

    The allergy diagnostic market is constantly evolving, with new technologies and solutions emerging to help those who suffer from allergies. One recent innovative solution comes from a startup that has raised USD 2 million to bring at-home allergy testing to everyone. These allergy drops will allow users to easily and accurately test themselves for a range of common allergies, from pollen to food. With the convenience of at-home testing, users will no longer have to wait weeks for allergy appointments or deal with the hassle of going to a clinic. This is an exciting development for the allergy diagnostic market, as it represents a major step forward in convenience and accessibility for those with allergies. [Published On: 2023-02-09]

  • AllerVie Health acquires Allergy, Sinus & Asthma family health center, densifies footprint in the villages, Florida

    Allervie Health, a leading provider of allergy and chronic sinusitis solutions, announced today their acquisition of Allergy, Sinus & Asthma Family Health Center located in The Villages, Florida. With this acquisition, Allervie Health continues to densify their footprint in Florida and expands its market for allergy diagnostics. Allergy, Sinus & Asthma Family Health Center has a long history of serving the community with high-quality healthcare, making this acquisition a perfect strategic fit for Allervie Health. This expansion will result in increased availability and access to cutting-edge allergy diagnostics services in the region, enabling patients to receive the best care possible to improve their quality of life. Allervie Health remains committed to providing advanced solutions for allergies and chronic sinusitis and is confident that this acquisition will drive greater growth and success in the allergy diagnostics market. [Published On: 2023-02-08]

  • Siemens launches centre of excellence for immunoassay instrument R&D in Ireland

    Siemens, the global technology powerhouse, has announced the launch of its Centre of Excellence for Immunoassay Instrument R&D in Ireland. The centre will be dedicated to the development of innovative allergy diagnostics and will focus on creating new solutions for the detection and monitoring of allergic diseases such as asthma, food allergies, and other immune disorders. With a highly skilled and experienced team, this new facility will explore and introduce new technologies that can better address unmet medical needs, while advancing the allergy diagnostics sector through a range of innovative solutions. This latest initiative demonstrates Siemens’ commitment to addressing medical challenges while pushing the boundaries of innovation in healthcare technology. [Published On: 2023-01-23]

Key Company Profiles

The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomérieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Drug Allergen
    • Food Allergen
    • Inhaled Allergen
  • Product Type
    • Assay Kits
    • Consumables
    • Instruments
      • Immunoassay Analyzers
      • Luminometers
  • Test
    • In-Vitro Tests
    • In-Vivo Tests
  • End User
    • Academic Research Institutes
    • Diagnostic Laboratories
    • Hospital-Based Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Allergy Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Allergy Diagnostics Market?
  4. What is the market share of the leading vendors in the Allergy Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Allergy Diagnostics Market, by Type
  7. Allergy Diagnostics Market, by Product Type
  8. Allergy Diagnostics Market, by Test
  9. Allergy Diagnostics Market, by End User
  10. Americas Allergy Diagnostics Market
  11. Asia-Pacific Allergy Diagnostics Market
  12. Europe, Middle East & Africa Allergy Diagnostics Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • ALK-Abelló A/S
  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • Bausch & Lomb Incorporated
  • Biomérieux SA
  • Danaher Corporation
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DST Diagnostische Systeme & Technologien GmbH
  • Erba Group
  • Eurofins Scientific
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HAL Allergy B.V.
  • Hitachi, Ltd.
  • HOB Biotech Group Corp., Ltd.
  • HollisterStier by Jubilant Life Sciences Limited
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporation
  • Omega Diagnostics Group PLC
  • Parkway Pantai Ltd.
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH by Royal DSM
  • ROXALL Medizin GmbH
  • Siemens AG
  • Stallergenes Greer International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Allergy Diagnostics Market
The Global Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024.
The Global Allergy Diagnostics Market to grow USD 11.80 billion by 2030, at a CAGR of 10.35%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.